Journal of Developing Drugs
Open Access

Department of Dermatology, Shalamar Institute of Health Sciences, Lahore, Pakistan

Publications

• Research Article   
  Mortality in Patients of COVID-19 when given Remdesivir in Early Stages of the Disease as Compared to Late Stages of the Disease in Pakistani Population
  Author(s): Zahabia Manzoor, Haaris Inam Khan*, Saddiq ul Abidin, Fatima Maqsood, Ahsan Farooq Khan, Syed Muhammad Sikandar, Alina Fakhar and Khalid Shahzad
  
  Background: Various drugs have been studied in the management of COVID-19 infection and the only antiviral that has been proven efficacious is Remdesivir which is a broad spectrum antiviral agent having activity against RNA dependent viral RNA polymerase. Objective: To compare the frequency of mortality in patients of COVID-19 when given Remdesivir in early stages of the disease as compared to the late stages of the disease. Study design: Retrospective comparative cross sectional study. Study setting Farooq hospital Lahore, Pakistan. Study duration: 12 Months. Data analysis: All patients admitted from January 2020 till December 2020 above 18 years of age of either gender diagnosed COVID-19 positive by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) with.. View More»
  DOI: 10.35248/ 2329-6631.22.11.175

  Abstract HTML PDF